Concepedia

Author

R. M. Borzilleri

Bristol-Myers Squibb (United States)ORCID

Also Known As

Borzilleri, R.M., Borzilleri, Robert M., R Borzilleri, R. Borzilleri, R. M. BORZILLERI, R. M. Borzilleri, Robert Borzilleri, Robert M Borzilleri, Robert M. Borzilleri

193

Publications

5.3K

Citations

33

H-Index

58

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Scripps Research InstituteBristol-Myers Squibb (Sweden)Bristol-Myers Squibb (Germany)Biocon (India)
RM

About

R. M. Borzilleri is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

31

3.4K

2

Natural Sciences

17

18

1.3K

3

Biochemistry

14

14

1.1K

4

Biomolecular Engineering

13

13

853

5

Engineering

8

8

500

R. M. Borzilleri

×

53

Publications

4.6K

Citations

31

H-Index

YearCitations

Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

Louis J. Lombardo, Francis Y. Lee, Ping Chen,

Journal of Medicinal Chemistry

2004

1.3K

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Francis Y. F. Lee, R. M. Borzilleri, Craig R. Fairchild,

PubMed

2001

455

Discovery of <i>N</i>-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily

Gretchen M. Schroeder, Yongmi An, Zhen‐Wei Cai,

Journal of Medicinal Chemistry

2009

276

Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form

Micah T. Nelp, Patrick A. Kates, John T. Hunt,

Proceedings of the National Academy of Sciences

2018

203

Decarboxylative Peptide Macrocyclization through Photoredox Catalysis

Stefan J. McCarver, Jennifer X. Qiao, Joseph Carpenter,

Angewandte Chemie International Edition

2016

147

Discovery of Brivanib Alaninate ((<i>S</i>)-((<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)

Zhen‐Wei Cai, Yongzheng Zhang, R. M. Borzilleri,

Journal of Medicinal Chemistry

2008

141

A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products

R. M. Borzilleri, Xiaoping Zheng, Robert J. Schmidt,

Journal of the American Chemical Society

2000

141

Discovery and Preclinical Studies of (<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5- methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor

Rajeev S. Bhide, Zhen‐Wei Cai, Yong‐Zheng Zhang,

Journal of Medicinal Chemistry

2006

131

Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities

Kyoung Soon Kim, Liping Zhang, Robert J. Schmidt,

Journal of Medicinal Chemistry

2008

121

Synthesis of the Vancomycin CD and DE Ring Systems

Dale L. Boger, R. M. Borzilleri, Seiji Nukui,

The Journal of Organic Chemistry

1997

98

Page 1